Oncology

News

Artist's impression of the London cancer centre

Backers submit plans for £1bn cancer district in London

A planning application has been filed to invest £1bn in "the world's leading centre for cancer research and treatment" in a London borough.

News

AACR 2025: MaaT Pharma, the gut microbiome, and immuno-oncol...

Lyon, France-based late-stage clinical biotech MaaT Pharma has presented new preclinical data for MaaT034 at AACR 2025.

News

Belén Garijo, Merck's chair and chief executive

Merck agrees $3.9 billion takeover of SpringWorks

Merck KGaA has reached an agreement with SpringWorks on a $47-per-share takeover deal that values the US biotech at $3.9 billion.

News

Dr Yu Xia, founder, chairwoman, president and chief executive of Akeso

Akeso PD-1 inhibitor cleared as Keytruda challenger advances

Akeso has bagged an FDA approval for its PD-1 inhibitor penpulimab and reported new data on highly-touted PD-1/VEGF bispecific ivonescimab.

News

Hands uniting in the centre of a circle of children

Irish study promises to revolutionise childhood cancer care

A five-year genomics study that aims to transform the care of children with cancer and improve treatment success has launched in Ireland.

News

Swiss biotech Veraxa vaults to Nasdaq listing with SPAC deal

Cancer drug developer Veraxa Biotech has reached a deal to merge with a SPAC in a deal that will give it a Nasdaq listing and a $1.6bn-plus valuation.

Backers submit plans for £1bn cancer district in London

AACR 2025: MaaT Pharma, the gut microbiome, and immuno-oncol...

Merck agrees $3.9 billion takeover of SpringWorks

Akeso PD-1 inhibitor cleared as Keytruda challenger advances

Irish study promises to revolutionise childhood cancer care

Swiss biotech Veraxa vaults to Nasdaq listing with SPAC deal

Delivering the right behavioural ingredients for the moment,...

How to meet your physicians where they are online

Oncology

Editor's Picks